Status:
UNKNOWN
Early POstoperative BIomarkers in PancreatoDuodenectomy: a Spanish Nationwide Study
Lead Sponsor:
Hospital Clínico Universitario de Valladolid
Conditions:
Pancreaticoduodenectomy
Eligibility:
All Genders
18+ years
Brief Summary
AIMS: To recruit a large nationwide Spanish series in order to register PF rate and other common morbidity after PD, and to perform external validation of the aforementioned score, as well as to analy...
Detailed Description
BACKGROUND: Complications after pancreatoduodenectomy (PD) are common and pancreatic fistula (PF) is among the most relevant ones. There are few studies analyzing blood parameters determined in the ea...
Eligibility Criteria
Inclusion
- benign or malignant condition requiring surgical treatment by PD.
- Signing the informed consent form
Exclusion
- Intra-operative findings of unresectability (pancreatic resection not be completed or palliative procedure performed)
- Other types of pancreatic resection (enucleations, distal and total pancreatectomies), as well as multivisceral resective procedures.
- Intraoperative radiotherapy
- ASA IV patients
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT04342923
Start Date
March 1 2021
End Date
May 1 2022
Last Update
June 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico Universitario
Valladolid, Spain, 47003